V002-5386 Screening compound: N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide

V002-5386 Screening compound: N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide
V002-5386 Screening compound: N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-5386
N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-5386

Molecular Formula

C30H30N4O3 (C30 H30 N4 O3)

Compound Name

N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide

IUPAC name

N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[2-phenyl-N-(prop-2-en-1-yl)acetamido]acetamide

SMILES

CCOc1cccc(-n2c(NC(CN(CC=C)C(Cc3ccccc3)=O)=O)nc(-c3ccccc3)c2)c1

InChI

InChI=1S/C30H30N4O3/c1-3-18-33(29(36)19-23-12-7-5-8-13-23)22-28(35)32-30-31-27(24-14-9-6-10-15-24)21-34(30)25-16-11-17-26(20-25)37-4-2/h3,5-17,20-21H,1,4,18-19,22H2,2H3,(H,31,32,35)

InChI Key

XBTFDEOMHYMKAO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19826603

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

494.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.828

Distribution Coefficient, logD

5.828

Water Solubility, LogSw

-5.32

Polar Surface Area

59.239

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

2.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

V002-5386 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V002-5386 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-5386?
Check Price and Availability of V002-5386, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-5386 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-5386
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-5386
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-5386 available by request